BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10634426)

  • 1. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
    Mannelli M; Gelmini S; Arnaldi G; Becherini L; Bemporad D; Crescioli C; Pazzagli M; Mantero F; Serio M; Orlando C
    J Clin Endocrinol Metab; 2000 Jan; 85(1):468-70. PubMed ID: 10634426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
    Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
    Pereira SS; Máximo V; Coelho R; Batista R; Soares P; Guerreiro SG; Sobrinho-Simões M; Monteiro MP; Pignatelli D
    J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of telomerase (hTERT) in aldosterone-producing adrenocortical tumors.
    Sticchi D; Fassina A; Ganzaroli C; Pasqualetto C; Pessina AC; Nussdorfer GG; Rossi GP
    Int J Mol Med; 2006 Mar; 17(3):469-74. PubMed ID: 16465394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
    Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
    Kanauchi H; Wada N; Clark OH; Duh QY
    Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in benign and malignant adrenal tumors.
    Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
    Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
    Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telomerase expression in various lesions of adrenal cortex].
    Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and Ki67 in adrenocortical tumors.
    Arola J; Salmenkivi K; Liu J; Kahri AI; Heikkilä P
    Endocr Res; 2000 Nov; 26(4):861-5. PubMed ID: 11196463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of hTERT mRNA expression in colorectal cancer.
    Niiyama H; Mizumoto K; Sato N; Nagai E; Mibu R; Fukui T; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2001 Jun; 96(6):1895-900. PubMed ID: 11419845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1 connexin 43 gap junctions are decreased in human adrenocortical tumors.
    Murray SA; Davis K; Fishman LM; Bornstein SR
    J Clin Endocrinol Metab; 2000 Feb; 85(2):890-5. PubMed ID: 10690907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
    de Sousa GR; Ribeiro TC; Faria AM; Mariani BM; Lerario AM; Zerbini MC; Soares IC; Wakamatsu A; Alves VA; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Oncotarget; 2015 Sep; 6(26):22724-33. PubMed ID: 26087193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
    Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
    Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.